30: FAVIPIRAVIR IN HOSPITALIZED COVID-19 PATIENTS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Aiman Naveed; Huzaifa Cheema; Abia Shahid; Harpreet Singh; Jonathan Kurman; Mohammad Ebad Ur Rehman; Mohammad Umer; Syeda Sahra; Faran Ahmad; Sharjeel Ahmad

doi:10.1097/01.ccm.0000998512.62294.18

Back

30: FAVIPIRAVIR IN HOSPITALIZED COVID-19 PATIENTS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Journal article

Peer reviewed

30: FAVIPIRAVIR IN HOSPITALIZED COVID-19 PATIENTS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Aiman Naveed, Huzaifa Cheema, Abia Shahid, Harpreet Singh, Jonathan Kurman, Mohammad Ebad Ur Rehman, Mohammad Umer, Syeda Sahra, Faran Ahmad and Sharjeel Ahmad

Critical care medicine, Vol.52(1), pp.S15-S15

01/2024

DOI: https://doi.org/10.1097/01.ccm.0000998512.62294.18

Metrics

1 Record Views

Details

Title: 30: FAVIPIRAVIR IN HOSPITALIZED COVID-19 PATIENTS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Creators: Aiman Naveed - King Edward Medical University
Huzaifa Cheema - King Edward Medical University
Abia Shahid - King Edward Medical University
Harpreet Singh - Medical College of Wisconsin
Jonathan Kurman - Medical College of Wisconsin
Mohammad Ebad Ur Rehman - Rawalpindi Medical University
Mohammad Umer - King Edward Medical University
Syeda Sahra - University of Oklahoma Health Sciences Center
Faran Ahmad - Creighton University
Sharjeel Ahmad - Illinois College
Publication Details: Critical care medicine, Vol.52(1), pp.S15-S15
Identifiers: 991006062171502656
Academic Unit: Infectious Disease
Language: English
Resource Type: Journal article

30: FAVIPIRAVIR IN HOSPITALIZED COVID-19 PATIENTS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Related links

Metrics

Details